• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE Back to Search Results
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Abdominal Pain (1685); Peritonitis (2252)
Event Date 12/11/2023
Event Type  Injury  
Event Description
A peritoneal dialysis (pd) patient experienced a breach in aseptic technique which resulted in peritonitis.The breach in aseptic technique was not further described.The peritonitis was manifested by abdominal pain (which occurred a day prior to the peritonitis diagnosis) and cloudy pd fluid (which occurred on the same day as the peritonitis diagnosis).It was reported that the patient was not hospitalized for the events.A day after the peritonitis diagnosis, the patient was treated with meropenem injection (1gm, per bag, intraperitoneal, ongoing) and heparin injection (2000 iu, per bag, intraperitoneal, ongoing) for peritonitis.Two days after the peritonitis diagnosis, the patient has recovered from cloudy pd fluid.At the time of this report, the patient was recovering from abdominal and peritonitis.Pd therapy was ongoing.The patient was retrained on the proper aseptic technique.No additional information is available.
 
Manufacturer Narrative
This report is for a breach in aseptic technique which resulted in peritonitis. per baxter labeling, users are instructed to use aseptic technique when performing peritoneal dialysis therapy. should additional relevant information become available, a supplemental report will be submitted.
 
Manufacturer Narrative
Additional information: b5 and b6.B5: upon follow-up, it was reported that antibiotic treatment were discontinued (on an unknown date).On an unknown date, pd therapy was discontinued.At the time of this report, the patient has recovered from peritonitis, abdominal pain (on an unknown date) and cloudy pd fluid (two days after the initial symptom onset).Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NI
Type of Device
SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE CORPORATION
ni
ni
ni
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key18454642
MDR Text Key332198232
Report Number1416980-2023-06949
Device Sequence Number1
Product Code KDJ
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
NI
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/13/2023
Initial Date FDA Received01/05/2024
Supplement Dates Manufacturer Received01/04/2024
Supplement Dates FDA Received01/29/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
DIANEAL 1.5% PD2.; DIANEAL 2.5% PD2.; UNKNOWN BAXTER PD DISPOSABLES.; UNKNOWN PD CATHETER.
Patient Outcome(s) Required Intervention;
Patient Age68 YR
Patient SexFemale
-
-